AI assistant
ABBOTT LABORATORIES — Director's Dealing 2007
May 2, 2007
29777_dirs_2007-05-01_98743f0a-7261-4e78-b9b9-ed7be292389f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-04-27
Reporting Person: REYNOLDS W ANN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-04-27 | Common shares without par value | A | 1730 | — | Acquired | 38732 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 1707 | Indirect |
| Common shares without par value | 728 | Indirect |
Footnotes
F1: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).
F2: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11.
F3: The reporting person disclaims beneficial ownership of all securities held by her husband.